TRT side effects: what fitness influencers get right and wrong

What's this video probably claiming?

Based on the caption and creator context, @fitover50man is almost certainly running through a list of TRT downsides sourced from Dr. Mike Israetel's YouTube content. That likely includes: testicular atrophy from suppressed LH and FSH, fertility impacts, polycythemia (elevated red blood cell count), potential cardiovascular concerns, and the psychological dependency some men develop on exogenous testosterone. The framing is positioned as harm reduction rather than anti-TRT advocacy, which is a reasonable stance. The creator is probably also touching on how men over 50 self-diagnose low T from fatigue and low libido without getting actual bloodwork, then pursue TRT expecting a transformation that lifestyle changes might have delivered. This is a legitimate conversation. The problem is that sourcing clinical claims from a sports physiology PhD's YouTube video, rather than from peer-reviewed endocrinology literature, introduces gaps. Israetel is credentialed and generally careful, but YouTube is not a clinical reference.

What does the science actually show?

The side effects associated with TRT are real, documented, and dose-dependent. Testicular atrophy occurs because exogenous testosterone suppresses the hypothalamic-pituitary-gonadal axis, reducing LH and FSH. A 2013 study by Coviello et al. in the Journal of Clinical Endocrinology and Metabolism confirmed that intramuscular testosterone dose-dependently suppressed spermatogenesis. Polycythemia is clinically meaningful: hematocrit elevations above 54% are observed in roughly 5-10% of TRT patients depending on the formulation and dose, per Bachman et al. (2010, Annals of Internal Medicine). Cardiovascular risk has been the most contested area. The 2023 TRAVERSE trial (Lincoff et al., NEJM) followed 5,246 men with hypogonadism and found TRT did not significantly increase major adverse cardiovascular events compared to placebo over a median 33 months, partially rehabilitating TRT's cardiovascular safety profile that was damaged by flawed 2010 and 2014 studies. Fertility suppression is largely reversible but can take 6-18 months post-cessation, and recovery is not guaranteed in all men.

Where does the social media noise diverge from clinical reality?

The biggest distortion on TRT content is the binary framing: either TRT is dangerous and you should avoid it, or it is a life-changing optimization tool every man over 40 should explore. Both camps are wrong. Clinical hypogonadism, defined as total testosterone below 300 ng/dL with confirmed symptoms on two separate morning draws, affects an estimated 2-4% of adult men (Bhasin et al., 2018, JCEM). Yet TRT prescription rates increased over 300% between 2001 and 2013 (Baillargeon et al., 2013, JAMA). That gap suggests significant off-label use in men who are tired and want more energy but are not clinically deficient. Social media amplifies this by presenting high-normal optimization as equivalent to treating actual hypogonadism. It is not. The risk-benefit calculus looks very different for a 52-year-old with a total T of 180 ng/dL and documented symptoms versus a 38-year-old with a total T of 420 ng/dL who is sleep-deprived and undertrained. Most fitness influencer TRT content does not make this distinction clearly enough.

What should you actually know?

If you are considering TRT, the starting point is accurate diagnosis, not a TikTok video or a wellness clinic that measures testosterone at 3pm and prescribes the same week. Total testosterone should be measured twice, in the morning, after fasting. Free testosterone and SHBG matter too, because a man with low SHBG can have adequate free T despite a low total T number. The Endocrine Society's 2018 clinical practice guidelines recommend against TRT in men without confirmed hypogonadism. If you do have confirmed low T, the side effect profile is manageable with monitoring: hematocrit checks every 3-6 months, PSA baseline before starting if you are over 40, and a frank conversation about fertility plans. Formulation matters too. Gels, injections, and pellets have meaningfully different pharmacokinetic profiles. Anyone framing TRT as a simple plug-and-play intervention is leaving out the part where your body's own hormone production shuts down in response. That is not a scare tactic. That is endocrinology.